Anebulo Pharmaceuticals, Inc. (ANEB) — Operating Income
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$9.22M | -11.0% |
| 2024 | -$8.31M | +29.5% |
| 2023 | -$11.78M | -72.5% |
| 2022 | -$6.83M | -89.0% |
| 2021 | -$3.61M | — |
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$9.22M | -11.0% |
| 2024 | -$8.31M | +29.5% |
| 2023 | -$11.78M | -72.5% |
| 2022 | -$6.83M | -89.0% |
| 2021 | -$3.61M | — |